Lv2
196 积分 2025-05-20 加入
Neoadjuvant Chemoimmunotherapy in Resectable IIIA/IIIB Non-small Cell Lung Cancer
6天前
已完结
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
6天前
已完结
Postoperative radiotherapy for pigmented villonodular synovitis (PVNS): case series and literature review
11天前
已完结
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
3个月前
已完结
CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients
5个月前
已完结
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
5个月前
已完结
Single-cell profiling reveals the heterogeneity of NK cells during anti-PD-1 therapy in non-small-cell lung cancer
5个月前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
5个月前
已完结
Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer
5个月前
已完结
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
